REQUEST A DEMO
Total
USD $0.00
Search more companies

Apteka Eskulap Sp. z o.o. (Poland)

Main Activities: Department Stores
Secondary Activities: Pharmaceutical and Medicine Manufacturing | Merchant Wholesalers, Durable Goods | Retail Trade | Advertising, Public Relations, and Related Services | Marketing Research and Public Opinion Polling
Full name: Apteka Eskulap Sp. z o.o. Profile Updated: May 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Apteka Eskulap Sp. z o.o. is based in Poland. The head office is in Parczew. It operates in the Department Stores industry. The company was established on March 22, 2017. In its most recent financial highlights, the company reported a net sales revenue drop of 2.24% in 2023. During that time, Apteka Eskulap Sp. z o.o.’s total assets grew by 12.03%. The net profit margin of Apteka Eskulap Sp. z o.o. decreased by 3.24% in 2023.

Headquarters
Ul. Koscielna 19
Parczew; Lubelskie; Postal Code: 21-200

Contact Details: Purchase the Apteka Eskulap Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Apteka Eskulap Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Apteka Eskulap Sp. z o.o. report to view the information.
Incorporation Date:
March 22, 2017
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Apteka Eskulap Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-2.24%
Total operating revenue
-2.27%
Operating profit (EBIT)
-273.91%
Net Profit (Loss) for the Period
-269.77%
Total assets
12.03%
Total equity
-20.44%
Operating Profit Margin (ROS)
-3.24%
Net Profit Margin
-3.24%
Return on Equity (ROE)
11.44%
Quick Ratio
0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?